MONTREAL, June 18 - Neptune Technologies & Bioressources Inc. increases its visibility in the American retail market of natural supplements.
In fact, Albertsons, the third largest drug chain in the United States, geographically based in 31 states, with sales of $ 16.8 billion annually and the fifth largest in store count, will offer, at the beginning of July 2003, 3 Neptune products introduced under the brand name PurKrill and distributed by Laboratoire Lalco, an important strategic partner.
"We are very proud of this first breakthrough of PurKrill in the US. This confirms our strategic choice to establish privileged relationships with Neptune so we can offer to consumers some natural products such as Neptune Krill Oil under the brand name PurKrill. We are confident that PurKrill will have the same success over in the US", commented Mr. Jean-Pierre Veilleux, President of Laboratoire Lalco. "The agreement signed with Albertsons represents the first of a series of opportunities waiting for us in the US", he added.
Albertsons will introduce three new products: PurWoman, product clinically proven to reduce both the physical and emotional symptoms related to the Premenstrual Syndrome (PMS), ProtectSun, product taken orally as a skin protection against free radical damage from sunlight (UV) and environmental toxins as well as 3-6-9 Omega, beneficial for cardiovascular health, effective for joint health, alertness & mental focus and valuable for its anti-aging properties.
"This tremendous accomplishment is the result of many efforts from Neptune Technologies & Bioressources Inc. in the mass market penetration. To be associated to one of the largest drug retailers in the world represents an important step of our Development Plan and confirms the potential of Neptune products as unique nutritional supplements. It gives Neptune an unconditional credibility in the nutraceutical marketplace", comments Mr. Dave Randle, Vice-President of Sales - USA at Neptune Technologies & Bioressources. "Our plans are to roll out other major retailers throughout the balance of the year", added Mr. Randle.
Neptune Technologies & Bioressources Inc. develops and exploits marine biomasses with its extraction processes utilizing marine biomasses such as krill and other underexploited marine resources such as red crab and calanus. The company is industrializing its extraction process "Neptune OceanExtract" in order to offer its products to nutraceutical, cosmetic, cosmeceutical and biopharmaceutical markets.
Due to its technologies, Neptune Technologies & Bioressources Inc. is strategically well positioned in the huge and emerging markets based on the health and wellness concepts, markets in which natural biomass extraction will play an important role in developing nutrigenomics, the next wave in nutritional research.
Neptune Technologies & Bioressources Inc. is listed on the TSX-V Venture Exchange where its shares trade under the ticker symbol NTB. This transaction is therefore subject to its approval.
The TSX-V Venture Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this news release.